Company intelligence / Profile preview

Cardiovascular Systems

St. Paul, Minnesota, United Statescsi360.com ↗

Ownership: Private
Employees: ~600
Development stage: Other

Overview

Cardiovascular Systems’ orbital atherectomy devices are FDA-approved and used for the treatment of both peripheral and coronary artery disease, showing improved procedural success rates in complex arterial cases with extensive calcification, supported by clinical trials and broad adoption in US vascular/cardiology practices[5][1][3].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Cardiovascular Research Foundation (CRF)[9]

Beyond the preview

Go deeper on Cardiovascular Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiovascular Systems.